Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent and caregiver preferences toward antibiotic allergy delabeling in children.

Infection control and hospital epidemiology·2026
Same author

Feasibility and acceptability of an everyday patient-centered discussion model for primary care: An exploratory, single-center study in the VA primary care setting.

PEC innovation·2026
Same author

The Impacts of a Primary Care-Based Dietitian Health Coaching Intervention on Patients' Health: An Observational Study.

American journal of lifestyle medicine·2026
Same author

Evaluation of Alternative Smoking Duration Criteria for Lung Cancer Screening.

JAMA internal medicine·2026
Same author

MyLungHealth, a Patient-Facing Education Tool for Lung Cancer Screening: Qualitative User-Centered Design Study.

JMIR formative research·2026
Same author

The Potential for a Benefit-Estimating Algorithm to Improve Recommendations for Preventive Services: Comparing Algorithm Recommendations with Those of Primary Care Providers.

Medical decision making : an international journal of the Society for Medical Decision Making·2026

Related Experiment Video

Updated: Jun 22, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.6K

Prediction-Augmented Shared Decision-Making and Lung Cancer Screening Uptake.

Tanner J Caverly1,2, Renda S Wiener3,4, Kyle Kumbier1

  • 1Center for Clinical Management Research, Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.

JAMA Network Open
|July 1, 2024
PubMed
Summary

A new tool improved lung cancer screening (LCS) uptake by helping doctors identify high-benefit individuals. This personalized approach encourages screening more effectively, especially for those most likely to benefit from early detection.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K

Related Experiment Videos

Last Updated: Jun 22, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K

Area of Science:

  • Pulmonary Medicine
  • Health Services Research
  • Decision Science

Background:

  • Low-dose computed tomography lung cancer screening (LCS) uptake remains suboptimal, particularly among high-risk individuals with significant life expectancy.
  • Effective strategies are needed to improve LCS uptake and ensure equitable access for those who stand to benefit most.

Purpose of the Study:

  • To evaluate the impact of a prediction-augmented shared decision-making (SDM) tool on LCS uptake.
  • To assess if the tool enhances clinician ability to identify high-benefit candidates and tailor screening encouragement.

Main Methods:

  • A quality improvement interrupted time series study was conducted across six Veterans Affairs sites.
  • The study involved LCS-eligible individuals (aged 55-80, ≥30 pack-year smoking history) using clinical reminders to prompt SDM.
  • A decision support tool, enhanced by a prediction model, personalized SDM by tailoring screening encouragement based on predicted benefit.

Main Results:

  • In a cohort of 9904 individuals, 11% received screening. The tool implementation was associated with higher overall LCS uptake.
  • Benefit-based LCS uptake increased, with higher screening rates observed among individuals predicted to be at high benefit compared to intermediate benefit.
  • The mean predicted probability of screening was significantly higher for high-benefit individuals (24.8%) versus intermediate-benefit individuals (15.8%).

Conclusions:

  • Implementing a personalized LCS approach integrating SDM and a prediction-augmented decision support tool improves screening uptake.
  • This strategy is particularly effective for individuals most likely to benefit from lung cancer screening.
  • Findings are crucial given the persistent low rates of LCS uptake and highlight a pathway for optimization.